510(k) Report

510(k) · Cleared

Recalled · Class II · 2018

Venous Drainage Cannula with Duraflo Coating

K120072510(k) TraditionalCleared May 8, 2012119-day reviewClass II21 CFR 870.4210Recalls 4

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Edwards Lifesciences, LLC · DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass

Cleared on May 8, 2012 as substantially equivalent to K831769 (Research Industries Corp., 1983) and 2 other predicates after a 119-day review. Its family tree reaches back 1 generation to 1983. It has been recalled 4 times.

Decided
May 8, 2012
Review
119 days
Class
Class II
Product code
DWF
Recalls
4
Predicates
3

Its longest line of descent runs back 1 generation to K831769 (1983). 3 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2009: 1 other ancestor2004: 1 other ancestorK831769 · Various Cardiovascular Surgical Device · Research Industries Corp. · 1983 · recalled1980198519901995200020052010
Other ancestors, by generation 1 generation back: 2 other ancestors K831769 · Various Cardiovascular Surgical Device · Research Industries Corp. · 1983 · recalled0
  1. Root · 1 generation backK831769 Various Cardiovascular Surgical DeviceResearch Industries Corp. · 1983 · Recalled
  2. This deviceK120072 Venous Drainage Cannula with Duraflo CoatingEdwards Lifesciences, LLC · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K831769Various Cardiovascular Surgical DeviceResearch Industries Corp.19838
0 (this device)K120072Venous Drainage Cannula with Duraflo CoatingEdwards Lifesciences, LLC2012—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200410
200910
FIG. 1 — Lineage of K120072, 1983–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DWF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DWF device

  1. #1 K251258 MC2™ Two-Stage Venous Cannula; MC2X™…score 14.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K831769Various Cardiovascular Surgical Device
Summary page 1
…Bypass 21 CFR Part 870.4210, Product Code DWF, Class 11 Predicate Device: K831 769 - Venous Cannulae K033464 - Pediatric Venous Cannulae…
Research Industries Corp.19838
*K033464Edwards Lifesciences Research Medical Pediatric Venous Return Cannulae
Summary page 1
…21 CFR Part 870.4210, Product Code DWF, Class 11 Predicate Device: K831 769 - Venous Cannulae K033464 - Pediatric Venous Cannulae K092509 - Venous Cannulae Device Description: -- -…
Edwards Lifesciences, LLC20042
*K092509Edwards Lifesciences Venous Return Cannulae
Summary page 1
…Predicate Device: K831 769 - Venous Cannulae K033464 - Pediatric Venous Cannulae K092509 - Venous Cannulae Device Description: -- - -Edwards- Lifesciences venous return cannulae are soft-cannulae-with-en…
Edwards Lifesciences, LLC2009—

Also cleared against K831769: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 7, 2018Class IIZ-3029-2018Labeling False and MisleadingThe expiration date on the device labeling exceeds its actual validated shelf life because the sterilization process used does not have adequate support for the extended shelf life.
Mar 7, 2018Class IIZ-3030-2018Labeling False and MisleadingThe expiration date on the device labeling exceeds its actual validated shelf life because the sterilization process used does not have adequate support for the extended shelf life.
Mar 7, 2018Class IIZ-3031-2018Labeling False and MisleadingThe expiration date on the device labeling exceeds its actual validated shelf life because the sterilization process used does not have adequate support for the extended shelf life.
Nov 4, 2015Class IIZ-0398-2016Employee errorEdwards Lifesciences initiated a field action for the Thin-Flex Venous Cannula (Model TF292902A) because the connector size is incorrectly described in the Edwards product guide as 3/8 inch. The actual and correct connector size is 1/2…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 2 of the 3 ancestors have a recall of any class.
  • 3 other devices also cite its predicate K831769.

How does its category compare?

All DWF devices

DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · DWF

4in 2025

2007: 22008: 62009: 82010: 32011: 52012: 102013: 92014: 142015: 92016: 32017: 52018: 52019: 32020: 32021: 52022: 22023: 22024: 32025: 42026 (partial year): 8
2007high 14 (2014) · low 2 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DWF

89in 2025

2008: 95 days median2009: 148 days median2010: 62 days median2011: 85 days median2012: 110 days median2013: 110 days median2014: 110 days median2015: 46 days median2016: 32 days median2017: 127 days median2018: 30 days median2019: 120 days median2020: 30 days median2021: 358 days median2024: 29 days median2025: 89 days median2026 (partial year): 81 days median
2007high 358 (2021) · low 29 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DWF

4in 2024

2007: 252008: 252009: 212010: 262011: 132012: 372013: 14, 1 Class I2014: 62015: 3, 1 Class I2016: 32017: 2, 1 Class I2018: 102019: 22021: 32024: 42026 (partial year): 20
2007high 37 (2012) · low 0 (2020)2026

Class I (3 since 2007) Class II/III not classified

Adverse event reports per year · DWF

1,020in 2025

2007: 1212008: 1262009: 992010: 1972011: 2122012: 2332013: 2382014: 3252015: 2182016: 1442017: 1012018: 1182019: 1792020: 1422021: 1622022: 2762023: 4702024: 4012025: 1,020
2007high 1,020 (2025) · low 99 (2009)2025

MAUDE reports naming product code DWF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—25121
200869525126
200981482199
201036226197
201158513212
20121011037233
2013911014 (1)238
2014141106325
20159463 (1)218
20163323144
201751272 (1)101
201853010118
201931202179
20203300142
202153583162
20222—0276
20232—0470
20243294401
202548901,020
202688120—

What is it indicated for?

Single Stage Venous Cannulae: Venous return cannulae are intended for cannula drainage from the right atrium or superior and inferior vena cava during extracorporeal circulation for a duration of 6 hours. Venous cannulae may be used in pediatric populations or adult populations based on flow rate requirements and patient anatomy. Please see labeling for maximum flow rate information. Extracorporeal circuit components with a Duraflo coating are intended…

Read the full statement (164 words)

Single Stage Venous Cannulae:

Venous return cannulae are intended for cannula drainage from the right atrium or superior and inferior vena cava during extracorporeal circulation for a duration of 6 hours.

Venous cannulae may be used in pediatric populations or adult populations based on flow rate requirements and patient anatomy. Please see labeling for maximum flow rate information.

Extracorporeal circuit components with a Duraflo coating are intended for use in cardiopulmonary surgery when a heparin coated blood path is desired.

Dual Stage Venous Cannulae:

Dual drainage venous return cannulae are indicated for venous cannulation so that extracorporeal circulation of the venous blood to a heart-lung machine may be achieved, for a duration of 6 hours.

Venous cannulae may be used in pediatric populations or adult populations based on flow rate requirements and patient anatomy. Please see labeling for maximum flow rate information.

Extracorporeal circuit components with a Duraflo coating are intended for use in cardiopulmonary surgery when a heparin coated blood path is desired.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K120072: Venous Drainage Cannula with Duraflo Coating.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K120072

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026